For more than 50 years, Muscular Dystrophy UK has invested more than £50,000,000 into high-calibre research to find treatments and cures for muscular dystrophy and related neuromuscular conditions.
Muscular Dystrophy UK funds world-class pioneering research into potential treatments and cures for people with muscular dystrophy and related neuromuscular conditions, from basic science and translational research to clinical pilot studies.
Since it was established in 1959, the charity has contributed to crucial scientific breakthroughs in the field of muscular dystrophy and other neuromuscular conditions such as laying the foundations for the promising technology of ‘exon skipping’ which is currently being tested in clinical trials for boys with Duchenne muscular dystrophy and funding work that has led to a scientific breakthrough in finding a treatment for mitochondrial myopathy, which is now close to clinical trial.
- Muscular Dystrophy UK’s medical research programme has an international reputation for excellence, investing up to £1million each year, with more than 20 live projects taking place at any one time (from basic science to clinical trials).
- The charity invests in scientists of the future, funding PhD studentships in top UK universities. It also invests in specialist advice and education for clinicians with training and clinical fellowships.
- Muscular Dystrophy UK currently funds 12 PhD studentships, and has supported more than 500 young scientists develop careers within the field of neuromuscular science over the past 50 years.
- In the last five years, we have invested £2.3 million to fund research into Duchenne muscular dystrophy. We currently fund four Duchenne muscular dystrophy research projects in Oxford and London at a cost of more than £400,000.
It is an interesting question: where would we be without the Muscular Dystrophy Campaign funding? The basic answer is we wouldn’t be anywhere.”
Professor Doug Turnbull, Professor of Neurology at the University of Newcastle